Gene · 316
Papers2,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluating the Impact of CYP1A2 Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open-Label Study. | Pharmacol Res Perspect | 2026 | 42773719 | PubTator, text mining | PubMed |
| Clinical Pharmacokinetics and Disposition of Imrecoxib. | Clin Pharmacokinet | 2026 | 42754736 | PubTator, text mining | PubMed |
| Aryl hydrocarbon receptor as a molecular mediator in the induction of human aldehyde oxidase gene expression. | J Pharmacol Exp Ther | 2026 | 42664535 | PubTator, text mining | PubMed |
| Structure of human aldehyde oxidase under tris(2-carboxyethyl)phosphine reducing conditions. | Acta Crystallogr F Struct Biol Commun | 2026 | 42504845 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Analysis of 2,3,7,8-TCDD-induced Renal Cell Carcinoma Reveals Core Targets and Mechanistic Pathways. | Curr Med Chem | 2026 | 42474018 | PubTator, text mining | PubMed |
| Post-mortem degradation of flunitrazepam by aldehyde oxidase 1 and hemoglobin in blood. | Forensic Toxicol | 2026 | 42323760 | PubTator, text mining | PubMed |
| NOX4 suppresses malignant progression in prostate adenocarcinoma and functions as a potential diagnostic biomarker. | Transl Androl Urol | 2026 | 42293855 | PubTator, text mining | PubMed |
| Homeostasis of Molybdenum, Xanthine Oxidase and Aldehyde Oxidase Activity Levels in the Livers of Patients with End-Stage Liver Failure and Healthy Controls. | Int J Mol Sci | 2026 | 42278524 | PubTator, text mining | PubMed |
| Comparative transcriptomic analysis of endometrial tissue associated with uterine fibroids and endometrial polyps. | Sci Rep | 2026 | 42259941 | PubTator, text mining | PubMed |
| Role of pregnane X receptor in the upregulation of human aldehyde oxidase gene expression. | Biochem Pharmacol | 2026 | 42178049 | PubTator, text mining | PubMed |
| RNA-Binding Proteins Alter Redox Gene Splicing in Biliary Atresia: Insights from Expression Profiling. | ACS Omega | 2026 | 42040470 | PubTator, text mining | PubMed |
| Retraction Note: Improving AOX1 promoter efficiency by overexpression of Mit1 transcription factor. | Mol Biol Rep | 2026 | 42033504 | PubTator, text mining | PubMed |
| Proteomics-Informed Physiologically Based Pharmacokinetic Modeling for Aldehyde Oxidase Substrates in Colorectal Cancer Liver Metastasis. | Mol Pharm | 2026 | 42028959 | PubTator, text mining | PubMed |
| Glutathione-reversible inactivation of aldehyde oxidase by hydralazine contributes to inter-lot inhibition variability in human hepatocytes. | Drug Metab Pharmacokinet | 2026 | 41955649 | PubTator, text mining | PubMed |
| Research Progress Towards Poliovirus Virus-like Particle Vaccines: A Review. | Vaccines (Basel) | 2026 | 41893752 | PubTator, text mining | PubMed |
| TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis. | NeuroSci | 2026 | 41874031 | PubTator, text mining | PubMed |
| Probing uric acid-related prognostic genes and their molecular mechanisms in prostate cancer based on transcriptomic data. | Discov Oncol | 2026 | 41865319 | PubTator, text mining | PubMed |
| Advancing the bioassay ontology through integrated PK/PD and safety pharmacology representation. | J Biomed Semantics | 2026 | 41821121 | PubTator, text mining | PubMed |
| Next Generation DNA Damage Response Inhibitors: Harnessing Nanocarriers and Tumor Microenvironment for Precision Cancer Therapy. | Oncol Res | 2026 | 41799521 | PubTator, text mining | PubMed |
| Placenta tissue-based and circulating markers of cellular senescence in gestational diabetes mellitus. | Placenta | 2026 | 41785816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/316/papers